A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3†

Molecular Profiling in Non–Small Cell Lung Cancer: A Step Toward Personalized Medicine

(2013) Kirtee Raparia et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

(2013) D Gonzalez de Castro et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo

(2013) Mian Xie et al.   EUROPEAN JOURNAL OF CANCER

Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors

(2012) Kunihiko Minakata et al.   CANCER SCIENCE

E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry

(2012) Vijay Alla et al.   CELL CYCLE

Individualized chemotherapy in advanced NSCLC patients based on mRNA levels of BRCA1 and RRM1

(2012) Sheng-xiang Ren et al.   Chinese Journal of Cancer Research

Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection†

(2012) Tobias Walker et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Targeting megalin to enhance delivery of anti-clusterin small-interfering RNA nanomedicine to chemo-treated breast cancer

(2012) Hui Yi Xue et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Enhancement of Cisplatin Sensitivity in Lung Cancer Xenografts by Liposome-Mediated Delivery of the Plasmid Expressing Small Hairpin RNA Targeting Survivin

(2012) Hongwei Tian et al.   Journal of Biomedical Nanotechnology

FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients

(2012) Yu Wang et al.   LUNG CANCER

Correlation of Activated STAT3 Expression with Clinicopathologic Features in Lung Adenocarcinoma and Squamous Cell Carcinoma

(2012) Richeng Jiang et al.   Molecular Diagnosis & Therapy

Proliferation of human primary vascular smooth muscle cells depends on serum response factor

(2010) Daniela Werth et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC

(2010) Alex Chang   LUNG CANCER

Pharmacogenomics of platinum-based chemotherapy in NSCLC

(2009) Michelle AT Hildebrandt et al.   Expert Opinion on Drug Metabolism & Toxicology

Optimized Basic Conditions Are Essential for Successful siRNA Transfection into Primary Endothelial Cells

(2009) Andrea Nolte et al.   OLIGONUCLEOTIDES